Potential of gene therapy for brain tumors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Human Molecular Genetics

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/10.7.777PMID 11257112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular Endothelial Growth Factor (VEGF) in Astrocytic Gliomas – A Prognostic Factor?

  2004cited by this paper
• Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat

  2004cited by this paper
• Methods for Gene Delivery to Neural Tissue

  2001cited by this paper
• Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

  2001cited by this paper
• Viral Induced Demyelination

  2001cited by this paper
• Immunocytochemical characterization of long‐term persistent immune activation in human brain after herpes simplex encephalitis

  2000cited by this paper
• Human glioma immunobiology in vitro: implications for immunogene therapy.

  2000cited by this paper
• Targeting adenovirus

  2000cited by this paper
• Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.

  2000cited by this paper
• Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: Consequences for anti-cancer gene therapy

  2000cited by this paper
• Gene therapy of experimental brain tumors using neural progenitor cells

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Radiation to control gene expression

  2000cited by this paper
• Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.

  2000cited by this paper
• Evaluation of VP22 Spread in Tissue Culture

  2000cited by this paper
• Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.

  2000cited by this paper
• Hybrid vector designs to control the delivery, fate and expression of transgenes

  2000cited by this paper
• Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

  2000cited by this paper
• Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

  2000cited by this paper
• HSV.com: maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense.

  2000cited by this paper
• Helper Virus-Free Herpes Simplex Virus Type 1 Amplicon Vectors for Granulocyte-Macrophage Colony-Stimulating Factor-Enhanced Vaccination Therapy for Experimental Glioma

  2000cited by this paper
• Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

  2000cited by this paper
• Molecular Expression Analysis of Restrictive Receptor for Interleukin 13 , a Brain Tumor-associated Cancer / Testis Antigen

  2000cited by this paper
• Molecular circuitry regulating herpes simplex virus type 1 latency in neurons.

  2000cited by this paper
• Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.

  2000cited by this paper
• The identification of novel therapeutic targets for the treatment of malignant brain tumors.

  2000cited by this paper
• Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator

  2000cited by this paper
• Adenovirus-mediated transfer of Bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas

  2000cited by this paper
• Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

  2000cited by this paper
• Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

  2000cited by this paper
• Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.

  2000cited by this paper
• Recombinant Human Adenovirus: Targeting to the Human Transferrin Receptor Improves Gene Transfer to Brain Microcapillary Endothelium

  2000cited by this paper
• Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity

  2000cited by this paper
• Prodrug activation enzymes in cancer gene therapy

  2000cited by this paper
• A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme

  2000cited by this paper
• Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice

  2000cited by this paper
• Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.

  2000cited by this paper
• Connexin 43-enhanced suicide gene therapy using herpesviral vectors.

  2000cited by this paper
• Current status of viral gene therapy for brain tumours

  2000cited by this paper
• Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression

  2000cited by this paper
• Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.

  2000cited by this paper
• A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy

  2000cited by this paper
• Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage?

  2000cited by this paper
• Progress in antiangiogenic gene therapy of cancer

  2000cited by this paper
• Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models

  2000cited by this paper
• Noninvasive gene targeting to the brain.

  2000cited by this paper
• Generation of ribozyme-adenoviral vector against K-ras mutant human lung cancer cells

  2000cited by this paper
• Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene delivery

  2000cited by this paper
• Steering anti-cancer drugs away from the TRAIL

  2000cited by this paper
• Experimental Gene Therapy for Brain Tumors Using Adenovirus-Mediated Transfer of Cytosine Deaminase Gene and Uracil Phosphoribosyltransferase Gene with 5-Fluorocytosine

  2000cited by this paper
• Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein

  2000cited by this paper
• Pretreatment with Protease Is a Useful Experimental Strategy for Enhancing Adenovirus-Mediated Cancer Gene Therapy

  2000cited by this paper
• Mammalian neural stem cells.

  2000cited by this paper
• Ectodomain of Coxsackievirus and Adenovirus Receptor Genetically Fused to Epidermal Growth Factor Mediates Adenovirus Targeting to Epidermal Growth Factor Receptor-Positive Cells

  2000influential reference
• Design of a novel small peptide targeted against a tumor-specific receptor.

  2000cited by this paper
• Steering anti-cancer drugs away from the TRAIL.

  2000cited by this paper
• Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen

  2000cited by this paper
• Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.

  1999cited by this paper
• Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma.

  1999cited by this paper
• Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.

  1999cited by this paper
• Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22

  1999cited by this paper
• Antiangiogenic Gene Therapy in a Rat Glioma Model Using a Dominant-Negative Vascular Endothelial Growth Factor Receptor 2

  1999cited by this paper
• Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials

  1999cited by this paper
• Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule

  1999cited by this paper
• Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

  1999cited by this paper
• Novel Role for E 4 Region Genes in Protection of Adenovirus Vectors from Lysis by Cytotoxic T Lymphocytes

  1999cited by this paper
• In vivo protein transduction: delivery of a biologically active protein into the mouse.

  1999cited by this paper
• Single-Step Conversion of Cells to Retrovirus Vector Producers with Herpes Simplex Virus–Epstein-Barr Virus Hybrid Amplicons

  1999cited by this paper
• Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies.

  1999cited by this paper
• Immunobiology of the blood-brain barrier.

  1999cited by this paper
• Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells.

  1999cited by this paper
• "...those left behind." Biology and oncology of invasive glioma cells.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas

  1999cited by this paper
• Adenovirus-mediated Wild-type p53 Expression Induces Apoptosis and Suppresses Tumorigenesis of Experimental Intracranial Human Malignant Glioma

  1999cited by this paper
• Herpes virus vectors for gene therapy in the nervous system.

  1999cited by this paper
• Tumor Gene Therapy Made Easy: Allogeneic Major Histocompatibility Complex in the C6 Rat Glioma Model

  1999cited by this paper
• Herpes Simplex Virus as an in Situ Cancer Vaccine for the Induction of Specific Anti-Tumor Immunity

  1999cited by this paper
• Adenovirus-mediated gene transfer of dominant negative Ha-Ras inhibits proliferation of primary meningioma cells.

  1999cited by this paper
• Adenovirus vectors for gene delivery.

  1999cited by this paper
• Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.

  1999cited by this paper
• Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas.

  1999cited by this paper
• Novel Role for E4 Region Genes in Protection of Adenovirus Vectors from Lysis by Cytotoxic T Lymphocytes

  1999cited by this paper
• Preclinical Development Strategies for Novel Gene Therapeutic Products

  1999cited by this paper
• Expression of Human α(1,3)Fucosyltransferase Antisense Sequences Inhibits Selectin-mediated Adhesion and Liver Metastasis of Colon Carcinoma Cells

  1999cited by this paper
• Primary central nervous system tumors in adults

  1999cited by this paper
• Gene therapy using HVJ-liposomes: the best of both worlds?

  1999cited by this paper
• Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.

  1999cited by this paper
• Plasticity and stem cells in the vertebrate nervous system.

  1998cited by this paper
• Viral and nonviral gene delivery vectors for cancer gene therapy.

  1998cited by this paper
• Selective intraarterial gene delivery into a canine meningioma.

  1998cited by this paper
• In Vitro Cell-Free Conversion of Noninfectious Moloney Retrovirus Particles to an Infectious Form by the Addition of the Vesicular Stomatitis Virus Surrogate Envelope G Protein

  1998cited by this paper
• Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA

  1998cited by this paper
• The molecular genetics of central nervous system tumors

  1998cited by this paper
• Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumors

  1998cited by this paper
• Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.

  1998cited by this paper
• Reovirus therapy of tumors with activated Ras pathway.

  1998cited by this paper
• Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy.

  1998cited by this paper
• Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.

  1998cited by this paper
• Chemosensitivity of human malignant glioma: modulation by p53 gene transfer

  1998cited by this paper

• Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies

  2023cites this paper
• Stem Cells and Targeted Gene Therapy in Brain and Spinal Cord Tumors.

  2023cites this paper
• Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.

  2016cites this paper
• Chapter 1: Introduction

  2016cites this paper
• Mutations of the human interferon alpha-2b gene in brain tumor patients exposed to different environmental conditions

  2015cites this paper
• Synergism between cryoablation and GM-CSF: enhanced immune function of splenic dendritic cells in mice with glioma

  2015cites this paper
• From Gliomagenesis to Multimodal Therapeutic Approaches into High-Grade Glioma Treatment

  2013cites this paper
• Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma.

  2013cites this paper
• Animal models for anti-angiogenic therapy of malignant glioma

  2012cites this paper
• Fundamentals of Gene and Viral Therapy for Malignant Gliomas

  2011cites this paper
• Vstat120 modulates inhibits oncolytic viral therapy induced angiogenesis and innate pro-inflamatory response, augmenting oncolytic viral thereapy of glioblastom multiforme

  2011cites this paper
• Novel biosensors for preclinical brain tumor analysis

  2011cites this paper
• Adenovirus-Based Gene Therapy for Cancer

  2011cites this paper
• Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration.

  2010influential citation
• Engineering Herpes Simplex Virus for Cancer Oncolytic Virotherapy

  2010cites this paper
• Synthesis and evaluation of new 1,2,3,4-tetrahydroisoquinoline analogs as antiglioma agents

  2010cites this paper
• Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking.

  2009cites this paper
• Mutant sodium channel for tumor therapy.

  2009cites this paper
• Glioblastoma : between bed and bench

  2009cites this paper
• Concepts in genetic medicine

  2008cites this paper
• Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus.

  2008cites this paper
• Preventing growth of brain tumors by creating a zone of resistance.

  2008cites this paper
• Cancer and the Nervous System

  2008cites this paper
• Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma

  2007cites this paper
• Normal Brain Cells Contribute to the Bystander Effect in Suicide Gene Therapy of Malignant Glioma

  2007cites this paper
• The status of gene therapy for brain tumors

  2007cites this paper
• The Impact of Microarray Technology in Brain Cancer

  2007cites this paper
• In Vivo Vaccination With Tumor Cell Lysate Plus CpG Oligodeoxynucleotides Eradicates Murine Glioblastoma

  2007cites this paper
• Future prospects of transplantation therapy for neurological diseases using adult bone marrow stromal cells

  2006cites this paper
• Chemotherapy-Activating Gene Therapy

  2006cites this paper
• Studies on viral gene transfer and angiogenesis inhibition in experimental glioma models

  2006cites this paper
• Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia.

  2006cites this paper
• Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.

  2006cites this paper
• Oncolytic adenoviral therapy for glioblastoma multiforme.

  2006cites this paper
• HSV amplicon vectors for cancer therapy.

  2006cites this paper
• Uptake, cellular distribution and novel cellular binding proteins of immunostimulatory CpG oligodeoxynucleotides in glioblastoma cells

  2005cites this paper
• Sleeping beauty transposon-mediated gene therapy for prolonged expression.

  2005cites this paper
• Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.

  2005cites this paper
• Human gene therapy and imaging in neurological diseases

  2005cites this paper
• Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies.

  2005cites this paper
• Magnetic Resonance Imaging and Characterization of Spontaneous Lesions in a Transgenic Mouse Model of Tuberous Sclerosis as a Model for Endothelial Cell-Based Transgene Delivery

  2005cites this paper
• A Multimodal NMR study of Apoptosis Induced by HSV-tk Gene Therapy in a Rat Experimental Glioma Model

  2005cites this paper
• Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.

  2004cites this paper
• Vaccination with tumor cell lysate‐pulsed dendritic cells augments the effect of IFN‐β gene therapy for malignant glioma in an experimental mouse intracranial glioma

  2004cites this paper
• Gene therapy of the brain

  2004cites this paper
• Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.

  2004cites this paper
• Exploiting biology for therapeutic gain

  2004cites this paper
• Selective Transduction of Malignant Glioma by Lentiviral Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoproteins

  2004cites this paper
• Glioma-Specific and Cell Cycle-Regulated Herpes Simplex Virus Type 1 Amplicon Viral Vector

  2004cites this paper
• Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure

  2004cites this paper
• Gene Therapy for Human Malignant Brain Tumors

  2003cites this paper
• Gene Therapy with Virus Vectors for specific Disease of the Nervous System: Recombinant Retrovirus Vectors for Treatment of Malignant Brain Tumors

  2003cites this paper
• Clinical Trials with Retrovirus Mediated Gene Therapy – what Have we Learned?

  2003cites this paper
• Gene Therapy for Cancer

  2003cites this paper
• Intravascular Delivery of Neural Stem Cell Lines to Target Intracranial and Extracranial Tumors of Neural and Non-Neural Origin

  2003cites this paper
• Biophysical characterization of an integrin-targeted non-viral vector.

  2003cites this paper
• Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects.

  2003cites this paper
• Viral vectors for gene delivery to the nervous system

  2003cites this paper
• Potentiated Gene Delivery to Tumors Using Herpes Simplex Virus/Epstein-Barr Virus/RV Tribrid Amplicon Vectors

  2003cites this paper
• Classification of Glioblastoma Multiforme in Adults by Molecular Genetics

  2003cites this paper
• Evolution of a Gene Therapy Clinical Trial

  2003cites this paper
• Interleukin-13 Receptor-Directed Cytotoxin for Malignant Glioma Therapy: From Bench to Bedside

  2003cites this paper
• Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts

  2003cites this paper
• Evolution of a gene therapy clinical trial. From bench to bedside and back.

  2003cites this paper
• Potential New Methods for Antiepileptic Drug Delivery

  2002cites this paper
• Ex vivo and in vitro studies of transgene expression in rat astrocytes transduced with lentiviral vectors.

  2002cites this paper
• Critical Issues in Gene Therapy for Neurologic Disease

  2002cites this paper
• Oncoretrovirus and Lentivirus Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoprotein: Generation, Concentration, and Broad Host Range

  2002cites this paper
• Imaging Expression of Cytosine Deaminase-Herpes Virus Thymidine Kinase Fusion Gene (CD/TK) Expression with [124I]FIAU and PET

  2002cites this paper
• 29 – Radionuclide Imaging of Reporter Gene Expression

  2002cites this paper
• Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2.

  2002cites this paper
• Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET.

  2002cites this paper